Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004

2005 ◽  
Vol 19 (4) ◽  
pp. 433-455 ◽  
Author(s):  
Angelika C Gruessner ◽  
David ER Sutherland
2021 ◽  
Vol 22 ◽  
pp. 100311
Author(s):  
Satish K. Kedia ◽  
Bilal Ali ◽  
Yu Jiang ◽  
Hassan Arshad ◽  
Sanjaya K. Satapathy ◽  
...  

2021 ◽  
pp. 152692482110246
Author(s):  
Darryl C. Nethercot ◽  
Mita Shah ◽  
Lisa M. Stocks ◽  
Jeffrey M. Trageser ◽  
Victor Pretorius ◽  
...  

As organ procurement organizations nationwide see an increased opportunity to retransplant already transplanted hearts, we would like to share the overview and process of our 2 successful cases. Heart retransplantation increased our cardiac placement rates by 2.64% and 2% in 2015 and 2019, respectively. Spread across a nation that sees over 3500 heart placements annually, a 2% increase would be substantial. Since 2009, our cases stand as the only documented heart retransplantations in the United States. However, United Network for Organ Sharing data shows that potential exists. From a facilitation perspective, we have developed a protocol to ease the matching process. From a surgical perspective, these cases had no complications and saved 2 lives, with each heart now beating in a third person. We hope that by sharing our process and success, we can familiarize fellow organ procurement organizations and transplant communities with this viable opportunity.


2003 ◽  
Vol 47 (3) ◽  
pp. 243-247 ◽  
Author(s):  
João Eduardo Nicoluzzi ◽  
Carlos W. Marmanillo ◽  
João Carlos D. Repka

O transplante pancreático é a melhor opção para substituir a função endócrina da glândula em pacientes com diabetes do tipo 1 (DM1). Ao final de 2001, já haviam sido notificados mais de 17.000 transplantes de pâncreas ao International Pancreas Transplant Registry. Na atualidade o transplante reno-pancreático simultâneo é o melhor tratamento para pacientes com DM1 e insuficiência renal crônica. Neste estudo são apresentados os resultados do transplante simultâneo de rim-pâncreas (SRP) realizados em um centro brasileiro. MÉTODOS: De 01/2001 a 06/2002, 12 pacientes com DM1 e insuficiência renal associada foram submetidos a transplante SRP. A terapia imunossupressora consistiu de tacrolimus, micofenolato mofetil, esteróides e terapia de indução com basiliximab. RESULTADOS: No seguimento de 5,7 meses (1-18), as taxas de sucesso para pâncreas e rim foram respectivamente de 75% e 83%. A sobrevida dos pacientes foi de 83%. Ocorreram algumas complicações sérias, como trombose de 3 pâncreas (25%) e 2 rins (16%) e 2 fístulas ureterais (16%), porém nenhuma delas ocasionou óbito de qualquer paciente. Não ocorreu nenhum episódio de rejeição nos pacientes transplantados. Todos os doentes com enxertos funcionantes apresentam-se normoglicêmicos sem necessidade de insulina. CONCLUSÕES: Estes resultados demonstram que o SRP é um tratamento seguro e eficaz no manejo do doente diabético com insuficiência renal associada.


1998 ◽  
Vol 30 (2) ◽  
pp. 242-243 ◽  
Author(s):  
A.C Gruessner ◽  
D.E.R Sutherland ◽  
R.W.G Gruessner

2021 ◽  
pp. 55-60
Author(s):  
Martha Gershun ◽  
John D. Lantos

This chapter seeks to understand the motivations of people who offered to donate a kidney to a stranger. It explores the degree of emotional relationship that was essential to justify the claim that donation provided a psychological benefit to the donor. The chapter also mentions a law in the United Kingdom called the Unrelated Live Transplant Registry Authority which required organ donors to provide proof that they had a relationship with the recipient. In the United States, however, there is no federal legislation or public policy regulating stranger donors. The chapter then turns to discuss a study led by nephrologist Aaron Spital showing how attitudes within the transplant community gradually shifted from almost universal rejection of stranger donors to their gradual acceptance. It assesses the struggles that nephrologists went through in trying to determine whether such altruists were noble or irrational. Ultimately, the chapter offers a unique glimpse into the motivations of an altruistic donor and into the forms of skepticism that doctors and psychologists bring to evaluations of such donors.


Sign in / Sign up

Export Citation Format

Share Document